MMP9 and cancer: The tertiary granule component MMP-9 (113) has been implicated in NET-induced dormant cancer cell reactivation (114) and its possible reduced abundance in banded neutrophils and earlier neutrophil precursors present in cancer could reduce their ability to promote this reactivation.